Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials completed
295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 295 First-in-human Phase I trial of IBI188, an anti-CD47 targeting monoclonal antibody, in patients with advanced solid tumors and lymphomas